☆ 4.7 Article

Specificities of the DMD Gene Mutation Spectrum in Russian Patients

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial

Laurent Servais et al.

Summary: The study aimed to evaluate the long-term safety and efficacy of golodirsen treatment in ambulatory patients with exon 53 skip-amenable Duchenne muscular dystrophy. Golodirsen increased dystrophin protein expression, showed a potential benefit in preserving ambulation ability, and demonstrated good safety profile over 3 years compared to external controls.

NUCLEIC ACID THERAPEUTICS (2022)

添加到收藏夹

Review Genetics & Heredity

Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot

Harry Wilton-Clark et al.

Summary: This review summarizes the current state of development of N-terminal antisense and gene therapies for Duchenne muscular dystrophy (DMD), mainly focusing on exon-skipping therapy for duplications and deletions, as well as microdystrophin therapy.

GENES (2022)

添加到收藏夹

Review Chemistry, Medicinal

Ataluren-Promising Therapeutic Premature Termination Codon Readthrough Frontrunner

Sylwia Michorowska

Summary: Around 12% of disease-causing mutations are in-frame nonsense mutations, leading to truncated proteins with little or no function. Ataluren is the only approved readthrough agent for treating patients with nonsense mutation Duchenne muscular dystrophy. Its journey from identification to clinical trials, pharmacokinetics, and potential applications in treating other diseases with underlying nonsense mutations are summarized.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Clinical Neurology

Gene Therapy for Duchenne Muscular Dystrophy

Nertiyan Elangkovan et al.

Journal of Neuromuscular Diseases (2021)

添加到收藏夹

Article Clinical Neurology

Exon-Skipping in Duchenne Muscular Dystrophy

Shin’ichi Takeda et al.

Journal of Neuromuscular Diseases (2021)

添加到收藏夹

Article Genetics & Heredity

Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries

Rita Selvatici et al.

Summary: Our study evaluated ethnic-related genetic assortments of DMD mutations in 328 patients from 12 countries, identifying remarkable allele heterogeneity and country-specific mutation landscapes. Whole-exome sequencing was shown to be effective for detecting DMD mutations, with a detection rate close to 90%, and also revealed ethnic-specific gene modifier haplotypes, indicating the potential impact of ethnicity on genetic diagnosis and drug eligibility.

NEUROLOGY-GENETICS (2021)

添加到收藏夹

Review Clinical Neurology

The DMD gene and therapeutic approaches to restore dystrophin

Fernanda Fortunato et al.

Summary: Duchenne muscular dystrophy is a severe X-linked disease characterized by progressive muscle weakness. The disease is caused by a variety of pathogenic variations in the DMD gene, leading to the absence or decreased amount of dystrophin protein. Innovative personalized therapies have emerged targeting restoration of dystrophin and secondary consequences of dystrophin deficiency.

NEUROMUSCULAR DISORDERS (2021)

添加到收藏夹

Article Medicine, General & Internal

Duchenne muscular dystrophy

Dongsheng Duan et al.

Summary: Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the DMD gene, leading to loss of muscle tissue and function as well as cardiomyopathy. Recent studies have deepened understanding of the disease and led to the development of multidisciplinary care guidelines and various therapeutic approaches.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Casimersen: First Approval

Matt Shirley

Summary: Casimersen is a drug approved for the treatment of Duchenne muscular dystrophy, with its first approval in the USA and ongoing Phase III development in other countries worldwide.

DRUGS (2021)

添加到收藏夹

Article Clinical Neurology

Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double-blind, placebo-controlled, dose-titration trial

Kathryn R. Wagner et al.

Summary: Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene, while casimersen is designed to produce truncated but functional dystrophin in patients amenable to exon 45 skipping. This study demonstrated that casimersen was well tolerated in DMD patients and showed dose-proportional plasma exposure, supporting further research in this population.

MUSCLE & NERVE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Theragnosis for Duchenne Muscular Dystrophy

Leonela Luce et al.

Summary: This study characterized the mutational spectrum of DMD in an Argentinian cohort and conducted a comparative analysis of Latin American frequencies of mutations amenable for available therapies. The molecular algorithm used was effective for achieving a high detection rate and played a crucial role in differential diagnosis and patient management.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

EMQN best practice guidelines for genetic testing in dystrophinopathies

Carl Fratter et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy

Kasia Dzierlega et al.

GENE THERAPY (2020)

添加到收藏夹

Article Health Care Sciences & Services

Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study

Eugenio Mercuri et al.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)

添加到收藏夹

Article Genetics & Heredity

The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study

Marcella Neri et al.

FRONTIERS IN GENETICS (2020)

添加到收藏夹

Article Clinical Neurology

Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping A Phase 2 Randomized Clinical Trial

Paula R. Clemens et al.

JAMA NEUROLOGY (2020)

添加到收藏夹

Review Genetics & Heredity

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update

Chengmei Sun et al.

GENES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Transport of Ca(2+)and Ca2+-dependent permeability transition in heart mitochondria in the early stages of Duchenne muscular dystrophy

Mikhail Dubinin et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene

Annalaura Torella et al.

PLOS ONE (2020)

添加到收藏夹

Review Clinical Neurology

Clinical Phenotypes of DMD Exon 51 Skip Equivalent Deletions: A Systematic Review

Megan A. Waldrop et al.

JOURNAL OF NEUROMUSCULAR DISEASES (2020)

添加到收藏夹

Review Clinical Neurology

Update in Duchenne and Becker muscular dystrophy

Megan A. Waldrop et al.

CURRENT OPINION IN NEUROLOGY (2019)

添加到收藏夹

Article Genetics & Heredity

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Xiangdong Kong et al.

BMC MEDICAL GENETICS (2019)

添加到收藏夹

Article Clinical Neurology

Mutational spectrum of Duchenne muscular dystrophy in Spain: Study of 284 cases

I. Vieitez et al.

NEUROLOGIA (2017)

添加到收藏夹

Review Chemistry, Medicinal

Eteplirsen in the treatment of Duchenne muscular dystrophy

Kenji Rowel Q. Lim et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

添加到收藏夹

Article Genetics & Heredity

The importance of genetic diagnosis for Duchenne muscular dystrophy

Annemieke Aartsma-Rus et al.

JOURNAL OF MEDICAL GENETICS (2016)

添加到收藏夹

Review Clinical Neurology

Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy

John Hyun Namgoong et al.

DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE (2016)

添加到收藏夹

Article Genetics & Heredity

The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

Catherine L. Bladen et al.

HUMAN MUTATION (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

Duchenne Muscular Dystrophy: From Diagnosis to Therapy

Maria Sofia Falzarano et al.

MOLECULES (2015)

添加到收藏夹

Article Multidisciplinary Sciences

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations

Jonas Juan-Mateu et al.

PLOS ONE (2015)

添加到收藏夹

Article Clinical Neurology

Duchenne and Becker Muscular Dystrophies

Kevin M. Flanigan

NEUROLOGIC CLINICS (2014)

添加到收藏夹

Article Clinical Neurology

Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up

Francesca Magri et al.

JOURNAL OF NEUROLOGY (2011)

添加到收藏夹

Article Genetics & Heredity

Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center

Yasuhiro Takeshima et al.

JOURNAL OF HUMAN GENETICS (2010)

添加到收藏夹

Article Biology

Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children

Mohammed T. Tayeb

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2010)

添加到收藏夹

Article Genetics & Heredity

Transcriptional Behavior of DMD Gene Duplications in DMD/BMD Males

F. Gualandi et al.

HUMAN MUTATION (2009)

添加到收藏夹

Article Genetics & Heredity

Mutational Spectrum of DMD Mutations in Dystrophinopathy Patients: Application of Modern Diagnostic Techniques to a Large Cohort

Kevin M. Flanigan et al.

HUMAN MUTATION (2009)

添加到收藏夹

Article Genetics & Heredity

Genotype-Phenotype Analysis in 2,405 Patients with a Dystrophinopathy Using the UMD-DMD Database: A Model of Nationwide Knowledgebase

Sylvie Tuffery-Giraud et al.

HUMAN MUTATION (2009)

添加到收藏夹

Article Neurosciences

Duchenne muscular dystrophy

AndrewJ Kornberg et al.

NEUROLOGY INDIA (2009)

添加到收藏夹

Article Genetics & Heredity

Duplications in the DMD gene

S. J. White et al.

HUMAN MUTATION (2006)

添加到收藏夹

Review Clinical Neurology

Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule

Annemieke Aartsma-Rus et al.

MUSCLE & NERVE (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Deletion and duplication screening in the DMD gene using MLPA

T Lalic et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2005)

添加到收藏夹

Review Biochemistry & Molecular Biology

Duchenne and Becker muscular dystrophy: From gene diagnosis to molecular therapy

M Matsuo

IUBMB LIFE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.